Nonalcoholic fatty liver disease in asymptomatic obese women(a)(a)The work was originated in the Biomedical Research Unit of The Mexican Social Security Institute at Durango, Mex.

Objective. To determine the clinical characteristics of NAFLD in asymptomatic obese women.Methods. A total of 457 asymptomatic obese women were enrolled in a cross-sectional study and allocated into groups with and without NAFLD. Irrespective of ALT levels, diagnosis of NAFLD was established by ultr...

Full description

Bibliographic Details
Main Authors: Heriberto Rodriguez-Hernandez, Miriam Cervantes-Huerta, Jose Luis Gonzalez, María Dolores Marquez-Ramirez, Martha Rodriguez-Moran, Fernando Guerrero-Romero, MD, PhD
Format: Article
Language:English
Published: Elsevier 2010-04-01
Series:Annals of Hepatology
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S1665268119316527
id doaj-9d8e49b2704b4fd78d730a0ec931e17c
record_format Article
spelling doaj-9d8e49b2704b4fd78d730a0ec931e17c2021-06-09T05:55:30ZengElsevierAnnals of Hepatology1665-26812010-04-0192144149Nonalcoholic fatty liver disease in asymptomatic obese women(a)(a)The work was originated in the Biomedical Research Unit of The Mexican Social Security Institute at Durango, Mex.Heriberto Rodriguez-Hernandez0Miriam Cervantes-Huerta1Jose Luis Gonzalez2María Dolores Marquez-Ramirez3Martha Rodriguez-Moran4Fernando Guerrero-Romero, MD, PhD5Biomedical Research Unit, Mexican Social Security Institute; Research Group on Diabetes and Chronic Illnesses, Durango, Mexico; Faculty of Medicine, Juarez University of Durango StateBiomedical Research Unit, Mexican Social Security InstitutePathology Department, General Hospital of the Mexican Social Security Institute Durango, Dgo. MéxicoRadiology Department, General Hospital of the Mexican Social Security Institute Durango, Dgo. MéxicoBiomedical Research Unit, Mexican Social Security Institute; Research Group on Diabetes and Chronic Illnesses, Durango, MexicoBiomedical Research Unit, Mexican Social Security Institute; Research Group on Diabetes and Chronic Illnesses, Durango, Mexico; Correspondence and reprint request:Objective. To determine the clinical characteristics of NAFLD in asymptomatic obese women.Methods. A total of 457 asymptomatic obese women were enrolled in a cross-sectional study and allocated into groups with and without NAFLD. Irrespective of ALT levels, diagnosis of NAFLD was established by ultrasonographic findings; irrespective of fibrosis, NASH was defined by hepatic histological changes.Results. One hundred ninety five (42.7%) women had elevated ALT levels. Diagnosis of NAFLD was established in 228 (49.9%) women; among women with NAFLD, 34 (14.9%) have ALT levels within the normal range. On the other hand, based on the healthy range for ALT levels (19 UI/L), 336 (73.5%) women had elevated ALT, but only 2 (0.9%) women with NAFLD exhibited ALT levels within normal healthy values. Furthermore, 93 (41%) women who had AST/ALT levels 3 1 underwent liver biopsy; of these, 90 (96.8%) had diagnosis of NASH and 3 (3.2%) of hepatic cirrhosis. Women with NAFLD were more obese and have higher fasting plasma glucose, triglycerides, ALT, and AST levels than obese women without NAFLD. Seventy six (16.6%) women had diagnosis of diabetes; of these 47 (61.8) in the NAFLD group.Conclusions. Results of this study support the statement that women with NAFLD have an adverse metabolic profile. Furthermore, our results show that hyperglycemia, hypertriglyceridemia and markers of liver injury such as AST/ALT ≥ 1 may be useful for early recognition of NAFLD.http://www.sciencedirect.com/science/article/pii/S1665268119316527ObesitySteatosisNAFLDDiabetesNASH
collection DOAJ
language English
format Article
sources DOAJ
author Heriberto Rodriguez-Hernandez
Miriam Cervantes-Huerta
Jose Luis Gonzalez
María Dolores Marquez-Ramirez
Martha Rodriguez-Moran
Fernando Guerrero-Romero, MD, PhD
spellingShingle Heriberto Rodriguez-Hernandez
Miriam Cervantes-Huerta
Jose Luis Gonzalez
María Dolores Marquez-Ramirez
Martha Rodriguez-Moran
Fernando Guerrero-Romero, MD, PhD
Nonalcoholic fatty liver disease in asymptomatic obese women(a)(a)The work was originated in the Biomedical Research Unit of The Mexican Social Security Institute at Durango, Mex.
Annals of Hepatology
Obesity
Steatosis
NAFLD
Diabetes
NASH
author_facet Heriberto Rodriguez-Hernandez
Miriam Cervantes-Huerta
Jose Luis Gonzalez
María Dolores Marquez-Ramirez
Martha Rodriguez-Moran
Fernando Guerrero-Romero, MD, PhD
author_sort Heriberto Rodriguez-Hernandez
title Nonalcoholic fatty liver disease in asymptomatic obese women(a)(a)The work was originated in the Biomedical Research Unit of The Mexican Social Security Institute at Durango, Mex.
title_short Nonalcoholic fatty liver disease in asymptomatic obese women(a)(a)The work was originated in the Biomedical Research Unit of The Mexican Social Security Institute at Durango, Mex.
title_full Nonalcoholic fatty liver disease in asymptomatic obese women(a)(a)The work was originated in the Biomedical Research Unit of The Mexican Social Security Institute at Durango, Mex.
title_fullStr Nonalcoholic fatty liver disease in asymptomatic obese women(a)(a)The work was originated in the Biomedical Research Unit of The Mexican Social Security Institute at Durango, Mex.
title_full_unstemmed Nonalcoholic fatty liver disease in asymptomatic obese women(a)(a)The work was originated in the Biomedical Research Unit of The Mexican Social Security Institute at Durango, Mex.
title_sort nonalcoholic fatty liver disease in asymptomatic obese women(a)(a)the work was originated in the biomedical research unit of the mexican social security institute at durango, mex.
publisher Elsevier
series Annals of Hepatology
issn 1665-2681
publishDate 2010-04-01
description Objective. To determine the clinical characteristics of NAFLD in asymptomatic obese women.Methods. A total of 457 asymptomatic obese women were enrolled in a cross-sectional study and allocated into groups with and without NAFLD. Irrespective of ALT levels, diagnosis of NAFLD was established by ultrasonographic findings; irrespective of fibrosis, NASH was defined by hepatic histological changes.Results. One hundred ninety five (42.7%) women had elevated ALT levels. Diagnosis of NAFLD was established in 228 (49.9%) women; among women with NAFLD, 34 (14.9%) have ALT levels within the normal range. On the other hand, based on the healthy range for ALT levels (19 UI/L), 336 (73.5%) women had elevated ALT, but only 2 (0.9%) women with NAFLD exhibited ALT levels within normal healthy values. Furthermore, 93 (41%) women who had AST/ALT levels 3 1 underwent liver biopsy; of these, 90 (96.8%) had diagnosis of NASH and 3 (3.2%) of hepatic cirrhosis. Women with NAFLD were more obese and have higher fasting plasma glucose, triglycerides, ALT, and AST levels than obese women without NAFLD. Seventy six (16.6%) women had diagnosis of diabetes; of these 47 (61.8) in the NAFLD group.Conclusions. Results of this study support the statement that women with NAFLD have an adverse metabolic profile. Furthermore, our results show that hyperglycemia, hypertriglyceridemia and markers of liver injury such as AST/ALT ≥ 1 may be useful for early recognition of NAFLD.
topic Obesity
Steatosis
NAFLD
Diabetes
NASH
url http://www.sciencedirect.com/science/article/pii/S1665268119316527
work_keys_str_mv AT heribertorodriguezhernandez nonalcoholicfattyliverdiseaseinasymptomaticobesewomenaatheworkwasoriginatedinthebiomedicalresearchunitofthemexicansocialsecurityinstituteatdurangomex
AT miriamcervanteshuerta nonalcoholicfattyliverdiseaseinasymptomaticobesewomenaatheworkwasoriginatedinthebiomedicalresearchunitofthemexicansocialsecurityinstituteatdurangomex
AT joseluisgonzalez nonalcoholicfattyliverdiseaseinasymptomaticobesewomenaatheworkwasoriginatedinthebiomedicalresearchunitofthemexicansocialsecurityinstituteatdurangomex
AT mariadoloresmarquezramirez nonalcoholicfattyliverdiseaseinasymptomaticobesewomenaatheworkwasoriginatedinthebiomedicalresearchunitofthemexicansocialsecurityinstituteatdurangomex
AT martharodriguezmoran nonalcoholicfattyliverdiseaseinasymptomaticobesewomenaatheworkwasoriginatedinthebiomedicalresearchunitofthemexicansocialsecurityinstituteatdurangomex
AT fernandoguerreroromeromdphd nonalcoholicfattyliverdiseaseinasymptomaticobesewomenaatheworkwasoriginatedinthebiomedicalresearchunitofthemexicansocialsecurityinstituteatdurangomex
_version_ 1721388602727858176